Cambridge, UK
Summary
This global biopharmaceutical company focuses on research and development of innovative medicines across various therapeutic areas, including oncology, cardiovascular, renal, metabolism, respiratory, immunology, and rare diseases. The company emphasizes precision medicine, transformative science, and digital health, aiming to improve patient outcomes and healthcare sustainability. It also engages in partnerships and collaborations to enhance its research capabilities and expand access to its medicines.
Based on content on astrazeneca.com
boehringer-ingelheim.com
Ingelheim am Rhein, Germany
Pharmaceuticals and Biotechnology
We offer API access to our data.
8 of 8 checks passed
Label
Value
Active Dates
24.9 years — Since Feb 2000
Web Hosting
Platform
E-Mail Provider
Mimecast
NAICS Code
325412
SIC 4 Digit Code
2834
SIC 2 Digit Code
28
Industry
1. Biopharmaceuticals
2. Pharmaceutical Preparation Manufacturing
Vendor
Source
Adobe identity provider
TXT Record
Amazon SES
TXT Record
Apple
TXT Record
Atlassian
TXT Record
Cisco CI
TXT Record
Docker
TXT Record
DocuSign
TXT Record
TXT Record
TXT Record
Mail.ru
TXT Record
Miro
TXT Record
MongoDB
TXT Record
OneTrust
TXT Record
Smartsheet
TXT Record
TeamViewer
TXT Record
Twilio
TXT Record
Mimecast
TXT Record
Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2000 |
|
|
|
|
|
|
|
|
|
|
|
|
2001 |
|
|
|
|
|
|
|
|
|
|
|
|
2002 |
|
|
|
|
|
|
|
|
|
|
|
|
2003 |
|
|
|
|
|
|
|
|
|
|
|
|
2004 |
|
|
|
|
|
|
|
|
|
|
|
|
2005 |
|
|
|
|
|
|
|
|
|
|
|
|
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
|
|
|
|
|
|
|
|
|
2008 |
|
|
|
|
|
|
|
|
|
|
|
|
2009 |
|
|
|
|
|
|
|
|
|
|
|
|
2010 |
|
|
|
|
|
|
|
|
|
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
2012 |
|
|
|
|
|
|
|
|
|
|
|
|
2013 |
|
|
|
|
|
|
|
|
|
|
|
|
2014 |
|
|
|
|
|
|
|
|
|
|
|
|
2015 |
|
|
|
|
|
|
|
|
|
|
|
|
2016 |
|
|
|
|
|
|
|
|
|
|
|
|
2017 |
|
|
|
|
|
|
|
|
|
|
|
|
2018 |
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|